US Patent Issued to Hoffmann-La Roche, Monash University on Dec. 16 for "IL-37 fusion proteins and uses thereof" (Australian, German, Swiss Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,434, issued on Dec. 16, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.) and Monash University (Clayton, Australia).

"IL-37 fusion proteins and uses thereof" was invented by Georg Tiefenthaler (Penzberg, Germany), Alexander Bujotzek (Penzberg, Germany), Laurent Lariviere (Penzberg, Germany), Felix Schumacher (Basel, Switzerland), Andrew Ellisdon (Clayton, Australia), Claudia Nold (Clayton, Australia), Marcel Nold (Clayton, Australia) and James Whisstock (Clayton, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to polypeptides, particularly fusion protein variants comprising interleukin-37 (IL-37) and...